iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMoors & Cabot, Inc.
Latest Disclosed Ownership9,041 shares
Latest Disclosed Value $ 1,526,573
Moors & Cabot, Inc. ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 8, 2026 - Moors & Cabot, Inc. filed a 13F-HR form disclosing ownership of 9,041 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,526,573 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 9,041 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,184,823 USD.

Moors & Cabot, Inc. has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,041 0 0.00 1,527 0.07 0.0653
2026-02-10 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,041 17 0.19 1,526 17.13 0.0653
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,024 -19,124 -67.94 1,303 -63.44 0.0568
2025-08-06 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 28,148 -905 -3.11 3,561 -4.15 0.1655
2025-05-08 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,053 558 1.96 3,716 -1.38 0.1885
2025-02-07 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 28,495 -87 -0.30 3,767 -9.47 0.1791
2024-11-08 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 28,582 -459 -1.58 4,162 4.39 0.2067
2024-08-09 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 29,041 -322 -1.10 3,986 -1.07 0.2122
2024-05-08 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,363 850 2.98 4,029 4.03 0.2184
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 28,513 412 1.47 3,873 12.72 0.2413
2023-11-08 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 28,101 -606 -2.11 3,436 -5.71 0.2330
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 28,707 -605 -2.06 3,645 -3.73 0.2420
2023-05-05 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,312 174 0.60 3,786 -1.05 0.2602
2023-02-10 2022-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 29,138 -95 -0.32 3,826 11.87 0.2666
2023-02-07 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 28,874 -359 4,407 0.2936
2022-11-08 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 29,233 -484 -1.63 3,419 -2.20 0.2606
2022-08-08 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 29,717 -12 -0.04 3,496 -9.76 0.2515
2022-05-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,729 726 2.50 3,874 -12.47 0.2384
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,003 1,029 3.68 4,426 -2.10 0.2722
2021-12-08 2021-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 27,974 24 0.09 4,521 -1.16 0.2841
2021-11-05 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,000 -17,950 10 0.0007
2021-08-10 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 27,950 -199 -0.71 4,574 7.78 0.3208
2021-05-12 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 28,149 2,507 9.78 4,244 9.27 0.3249
2021-02-11 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 25,642 -280 -1.08 3,884 10.66 0.3266
2020-11-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 25,922 8,649 50.07 3,510 48.48 0.3302
2020-08-13 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 17,273 8,810 104.10 2,364 160.07 0.2518
2020-05-12 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,463 -125 -1.46 909 -11.92 0.1321
2020-01-28 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,588 -215 -2.44 1,032 18.89 0.1036
2019-10-22 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,803 214 2.49 868 -7.36 0.0956
2019-07-18 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,589 -1,018 -10.60 937 -12.92 0.1187
2019-05-06 2019-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 9,607 -87 -0.90 1,076 14.83 0.1463
2019-05-01 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 19,214 9,520 2,152
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,694 672 7.45 937 -14.27 0.1471
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,022 1,512 20.13 1,093 32.81 0.1335
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,510 1,730 29.93 823 33.39 0.1109
2018-05-18 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,780 2,198 61.36 617 61.52 0.0816
2018-02-13 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,582 2,927 446.87 382 75.23 0.0506
2017-11-16 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 655 655 218 0.0315
2016-05-10 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -1,310 -100.00 0 -100.00
2016-02-09 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,310 -56 -4.10 445 7.75 0.0815
2015-11-17 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,366 -32 -2.29 413 -19.96 0.0763
2015-08-17 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,398 42 3.10 516 10.73 0.0839
2015-05-14 2015-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,356 -194 -12.52 466 -0.85 0.0777
2015-02-17 2014-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,550 -150 -8.82 470 0.86 0.0797
2014-11-12 2014-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,700 150 9.68 466 17.09 0.0793
2014-08-11 2014-06-30 13F ISHARES NASDQ BIOTEC ETF 464287556 1,550 25 1.64 398 10.25 0.0671
2014-05-08 2014-03-31 13F ISHARES NASDQ BIOTEC ETF 464287556 1,525 1,525 361 0.0913
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-01-28 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-10-22 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Call 30,000 30 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.